Follicular development impairment in polyendocrine metabolic ovarian syndrome: multidimensional pathophysiological networks and frontier therapeutic targets
Authors:
Open Access
- 7 October 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1879713
Abstract
Polyendocrine metabolic ovarian syndrome (PMOS) is a prevalent endocrine-metabolic disorder characterised by follicular arrest, anovulation, and elevated androgen levels. This review transcends single-dimensional analyses of PMOS pathology from neuroendocrine or metabolic perspectives, proposing an integrated multi-layered network model to systematically elucidate the pathological mechanisms underlying follicular arrest. Post-pubertal dysfunction of the hypothalamic-pituitary-ovarian axis interacts with systemic metabolic dysregulation, jointly establishing an ovarian microenvironment characterised by hyperandrogenism, hyperinsulinaemia, and chronic inflammation. This environment further induces self-reinforcing vicious cycles within follicles, manifesting as impaired granulosa-oocyte communication, immunometabolic reprogramming (e.g., M1 macrophage polarisation), and organelle stress (including mitochondrial dysfunction and endoplasmic reticulum stress). This localised cycle is consolidated and amplified by higher-level regulatory factors—including developmental epigenetic programming, the gut-brain-ovary axis, and circadian rhythms—ultimately establishing a pathologically entrenched state. Finally, this network-based understanding informs future research pathways, focusing on how emerging strategies—such as multi-omics integration, artificial intelligence, and stem cell secretome studies—can advance phenotype-directed precision interventions. This review aims to provide a systematic, dynamic theoretical framework for understanding the complex pathogenesis of PMOS and its potential therapeutic targets.Keywords
This publication has 163 references indexed in Scilit:
- Heme oxygenase-1 emerges as a critical regulator linking autophagy dysregulation, immune infiltration, and NOD-Like receptor signaling in PCOS pathogenesisInflammation Research, 2026
- Anti‐Müllerian hormone regulates ovarian granulosa cell growth in PCOS rats through SMAD4International Journal of Gynecology & Obstetrics, 2025
- CPEB1 induces autophagy and promotes apoptosis in ovarian granulosa cells of polycystic ovary syndromeMolecular Reproduction and Development, 2024
- The role of circadian clock in regulating cell functions: implications for diseasesMedcomm, 2024
- Gut microbiota–bile acid‐vitamin D axis plays an important role in determining oocyte quality and embryonic developmentClinical and Translational Medicine, 2023
- A comprehensive review on the impact of calcium and vitamin D insufficiency and allied metabolic disorders in femalesFood Science & Nutrition, 2023
- Diagnosis and Management of InfertilityJAMA, 2021
- APPL1 as an important regulator of insulin and adiponectin‐signaling pathways in the PCOS: A narrative reviewCell Biology International, 2020
- A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cellsJournal of Molecular Medicine, 2012
- Intercellular Communication via Connexin43 Gap Junctions Is Required for Ovarian Folliculogenesis in the MouseDevelopmental Biology, 2001